Zobrazeno 1 - 10
of 169
pro vyhledávání: '"Fereshteh, Ashtari"'
Autor:
Mohammad Ali Sahraian, Roya Abolfazli, Vahid Shaygannejad, Fereshteh Ashtari, Nastaran Majdinasab, Samira Navardi, Seyed Mohammad Baghbanian, Behnaz Sedighi, Abdorreza Naser Moghadasi, Mohammad Ali Nahayati, Hamidreza Ghalyanchi Langroodi, Seyed Ehsan Mohammadianinejad, Nahid Beladi Moghadam, Hormoz Ayromlou, Alireza Nikseresht, Masoud Ghiasian, Nazanin Razazian, Elnaz Asadollahzadeh, Araz Sabzvari, Hamidreza Kafi, Sogol Albooyeh
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract Multiple sclerosis is an inflammatory demyelinating disease and represents a global health concern. Ocrelizumab, a humanized IgG monoclonal antibody, selectively targets CD20 on B cells and CD20-expressing T cells. This study aimed to compar
Externí odkaz:
https://doaj.org/article/22f872912f694ea9ab54854678474b48
Autor:
Armin Adibi, Ghazal Zandieh, Behzad Zolfaghari, Fereshteh Ashtari, Vahid Shaygannejad, Iman Adibi
Publikováno v:
Clinical Nutrition Open Science, Vol 55, Iss , Pp 136-148 (2024)
Summary: Introduction: Multiple Sclerosis (MS) is an immune-mediated central nervous system disorder, often accompanied by fatigue, which can be an initial symptom. Cocoa, rich in antioxidants like flavonoids, has previously reduced fatigue in chroni
Externí odkaz:
https://doaj.org/article/a0a47fb099c04fcbbce5851dcdcb9bec
Autor:
Mehran Rashidi, Saba Naghavi, Neda Ramezani, Fereshteh Ashtari, Vahid Shaygannejad, Sayed Mohsen Hosseini, Iman Adibi
Publikováno v:
Journal of Central Nervous System Disease, Vol 16 (2024)
Background Appropriate treatment reduces the severity and duration of relapses in demyelinating diseases of Central Nervous System (CNS). If high-dose corticosteroids treatment fails, therapeutic plasma exchange (TPE) is considered as a rescue treatm
Externí odkaz:
https://doaj.org/article/4290ed7a222d4e2dba0a9caa7e6c487c
Autor:
Zahra Salehi, Mohammad Mehdi Naghizadeh, Sajjad Ghane Ezabadi, Azadeh Ebrahimitirtashi, Naghmeh Abbasi Kasbi, Faezeh Khodaie, Shahram Aliyari, Fereshteh Ashtari, Seyed Mohammad Baghbanian, Seyed Massood Nabavi, Samaneh Hosseini, Nazanin Razazian, Vahid Shaygannejad, Nastaran Majdi-Nasab, Mohammad Hossein Harirchian, Asghar Bayati, Hoda Kamali, Nahid Hosseni Nejad Mir, Nahid Beladi Moghadam, Maryam Poursadeghfard, Hossein Mozhdehipanah, Nazanin Jalali, Mohammad Ali Nahayati, Fardin Faraji, Naser Kamyari, Mohammad Ali Sahraian, Zhila Maghbooli, Sharareh Eskandarieh
Publikováno v:
Heliyon, Vol 10, Iss 12, Pp e32946- (2024)
Background: The rising prevalence of familial multiple sclerosis (MS) in Iran has spurred interest in the potential impact of parental consanguinity on the risk of developing the disease. This study aims to aggregate current knowledge on parental con
Externí odkaz:
https://doaj.org/article/e85d4a5095a544dca987d745e6095cf8
Publikováno v:
IEEE Access, Vol 12, Pp 62975-62985 (2024)
Multiple sclerosis (MS) is a chronic neurological disorder that targets the central nervous system, causing demyelination and neural disruption, which can include retinal nerve damage leading to visual disturbances. The purpose of this study is to de
Externí odkaz:
https://doaj.org/article/df2d8a3923974b389659a079271bf9a5
Autor:
Fereshteh Ashtari, Pouran Najarzadeh, Vahid Shaygannejad, Iman Adibi, Neda Ramezani, Fariba Davanian, Sahar Akbaripour, Majid Barekatain
Publikováno v:
Journal of Research in Medical Sciences, Vol 29, Iss 1, Pp 49-49 (2024)
Background The objective of this study was to investigate cognitive performance and brain volume profile in patients with neuromyelitis optica spectrum disorder (NMOSD) and multiple sclerosis (MS). Materials and Methods: In a historical cohort study,
Externí odkaz:
https://doaj.org/article/6b3713f1099249bcb3b35222d30e0b4c
Autor:
Farinaz Tabibian, Kiarash Azimzadeh, Vahid Shaygannejad, Fereshteh Ashtari, Iman Adibi, Mehdi Sanayei
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-12 (2023)
Abstract Behavioral aspects and underlying pathology of attention deficit in multiple sclerosis (MS) remain unknown. This study aimed to clarify impairment of attention and its relationship with MS-related fatigue. Thirty-four relapse-remitting MS (R
Externí odkaz:
https://doaj.org/article/3d6aa508e742414f92352710234f5e5f
Autor:
Neda Kasiri, Seyed Mostafa Ghannadian, Reza Hosseini, Leila Ahmadi, Mahshid Rahmati, Fereshteh Ashtari, Abbasali Pourazar, Nahid Eskandari
Publikováno v:
Cell Journal, Vol 25, Iss 5, Pp 307-316 (2023)
Objective: In spite of the advances in therapeutic modalities, morbidity, due to multiple sclerosis (MS), still remains high.Therefore, a large body of research is endeavouring to discover or develop novel therapies with improved efficacy fortreating
Externí odkaz:
https://doaj.org/article/a3087ab070f046ca81d90e05269a3d3a
Publikováno v:
Neurology Letters, Vol 2, Iss Supplementary 1 (20th Iranian Multiple Sclerosis Congress) (2023)
Background: Rituximab, a monoclonal antibody that targets and eliminates CD20+ B cells, has shown effectiveness in decreasing disease activity in patients with multiple sclerosis (pwMS). This study aimed to investigate disability, motor function, and
Externí odkaz:
https://doaj.org/article/79718b38a081409ea4a7eeddd291a3cd
Autor:
Ali Motahharynia, Ahmad Pourmohammadi, Armin Adibi, Vahid Shaygannejad, Fereshteh Ashtari, Iman Adibi, Mehdi Sanayei
Publikováno v:
eLife, Vol 12 (2023)
Working memory (WM) is one of the most affected cognitive domains in multiple sclerosis (MS), which is mainly studied by the previously established binary model for information storage (slot model). However, recent observations based on the continuou
Externí odkaz:
https://doaj.org/article/fa67a021f0c447a68d810019bd0a5b76